SEC Comment Letter for ACADIA PHARMACEUTICALS INC (ACAD) (CIK 0001070494) (ACAD) — Mar 4, 2010

ACADIA PHARMACEUTICALS INC (ACAD) (CIK 0001070494)
Date: March 4, 2010 · CIK: 0001070494 · Accession: 0000000000-10-012248

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 000-50768

Date

March 4, 2010

Author

Not clearly detected

Form

UPLOAD

Company

ACADIA PHARMACEUTICALS INC (ACAD) (CIK 0001070494)

Letter

Mail Stop 4720 March 4, 2010 Uli Hacksell, Ph.D. Chief Executive Officer ACADIA Pharmaceuticals Inc. 3911 Sorrento Valley Boulevard San Diego, CA 92121

Re: ACADIA Pharmaceuticals Inc. Form 10-K for the year ended 12/31/2008 Filed March 10, 2009 File No. 000-50768

Dear Dr Hacksell: We have completed our review of your Form 10-K and related filings and have no further comments at this time. S i n c e r e l y ,

J e f f r e y P . R i e d l e r A s s i s t a n t D i r e c t o r cc: D. Bradley Peck J. Patrick Loofbourrow Cooley Godward Kronish LLP 4401 Eastgate Mall San Diego, CA 92121 Fax: 858-550-6420

Show Raw Text

Mail Stop 4720
March 4, 2010
 Uli Hacksell, Ph.D.  Chief Executive Officer  ACADIA Pharmaceuticals Inc.  3911 Sorrento Valley Boulevard San Diego, CA 92121

Re: ACADIA Pharmaceuticals Inc.
 Form 10-K for the year ended 12/31/2008
Filed March 10, 2009
 File No. 000-50768

Dear Dr Hacksell:
  We have completed our review of your Form 10-K and related filings and have no
further comments at this time.           S i n c e r e l y ,

         J e f f r e y  P .  R i e d l e r          A s s i s t a n t  D i r e c t o r     cc: D. Bradley Peck
J. Patrick Loofbourrow Cooley Godward Kronish LLP 4401 Eastgate Mall San Diego, CA 92121 Fax: 858-550-6420

SecProbe.io